2023
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
Gelissen J, Adjei N, McNamara B, Mutlu L, Harold J, Clark M, Altwerger G, Dottino P, Huang G, Santin A, Azodi M, Ratner E, Schwartz P, Andikyan V. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. Annals Of Surgical Oncology 2023, 30: 5597-5609. PMID: 37358686, DOI: 10.1245/s10434-023-13757-0.Peer-Reviewed Original ResearchConceptsHyperthermic intraperitoneal chemotherapyIntraperitoneal chemotherapyOvarian cancerStage III epithelial ovarian cancerUse of HIPECEpithelial ovarian cancerHigh-quality evidenceOvarian cancer treatmentHIPEC useInterval cytoreductionCytoreductive surgeryNeoadjuvant chemotherapyPerioperative careHIPEC protocolsHIPEC techniqueTreatment modalitiesPatient outcomesSingle administrationTumor disseminationChemotherapyCancerCancer treatmentOptimal candidatesMain siteLife data
2009
Extragenital adenosarcoma: A case report, review of the literature, and management discussion
Huang GS, Arend RC, Sakaris A, Hebert TM, Goldberg GL. Extragenital adenosarcoma: A case report, review of the literature, and management discussion. Gynecologic Oncology 2009, 115: 472-475. PMID: 19712965, PMCID: PMC4451226, DOI: 10.1016/j.ygyno.2009.07.033.Peer-Reviewed Case Reports and Technical NotesConceptsSarcomatous overgrowthLiposomal doxorubicinHigh-grade bowel obstructionMixed epithelial-mesenchymal tumorsComplete clinical responseInitial cytoreductive surgeryCompletion of chemotherapyFavorable prognostic factorAggressive clinical behaviorCoexistent endometriosisConcurrent endometriosisBowel obstructionCytoreductive surgeryClinical responseExtragenital sitesPrognostic factorsCase reportClinical behaviorSecond surgeryMüllerian adenosarcomaRare caseAdenosarcomaEndometriosisChemotherapySurgery